Condition: Colorectal Cancer · Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
The study is being conducted to evaluate the safety, tolerability and efficacy of SHR-8068 injection in combination with anti-tumor therapies in subjects with colorectal cancer.
This description comes directly from the study's public registry record.
Chuanpei Huang · +86-021-61053363 · chuanpei.huang@hengrui.com
Always discuss trial participation with your own doctor first.
| The Sixth Affiliated Hospital of Sun Yat-sen University | Guangzhou, Guangdong, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07071714